Welcome to CDC stacks | Immunization for travelers - 42952 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Immunization for travelers
  • Published Date:
    03/03/09
  • Language:
    English
Filetype[PDF-81.60 KB]


Details:
  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
  • Keywords:
  • Description:
    Every year more and more Americans are traveling internationally — for vacation, business, and volunteerism, and to visit friends and family. Health risks for travelers are higher in developing countries and rural areas because of differences in sanitary conditions, available food and water sources, and immunization coverage. In developed areas, health risks are similar to those in the United States. Your risk of becoming ill while traveling depends in part on where you are traveling, the length of stay, activities while traveling, your health, and your vaccine history.

    CR124445

    f_imz_travelers.pdf

  • Document Type:
    Pamphlet (or booklet)
  • Collection(s):
    Stephen B. Thacker CDC Library collection
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Use of Japanese encephalitis vaccine in children : recommendations of the Advisory Committee on Immunization Practices, 2013
    Personal Author:
    Bocchini, Joseph A.; Rubin, Lorry; Fischer, Marc; Hills, Susan L.; Staples, J. Erin;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases.;
    Published:
    November 15, 2013
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 62, no. 45, p. 898-900
    Description:
    On June 19, 2013, the Advisory Committee on Immunization Practices (ACIP) voted to extend existing recommendations for use of inactivated Vero cell culture-derived Japanese encephalitis (JE) vaccine (JE-VC) (Ixiaro, Intercell Biomedical) to include c...
    Status:
    current
    File Type:
    Filetype[PDF - 201.04 KB]
  2. Yellow fever vaccine booster doses : recommendations of the Advisory Committee on Immunization Practices, 2015
    Personal Author:
    Staples, J. Erin; Bocchini, Joseph A.; Rubin, Lorry; Fischer, Marc;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases.;
    Published:
    June 19, 2015
    Series:
    MMWR. Morbidity and mortality weekly report, Vol. 64, no. 23, p. 647-50
    Description:
    On February 26, 2015, the Advisory Committee on Immunization Practices (ACIP) voted that a single primary dose of yellow fever vaccine provides long-lasting protection and is adequate for most travelers. ACIP also approved recommendations for at-risk...
    Status:
    current
    File Type:
    Filetype[PDF - 266.98 KB]
  3. Health information for international travel 2001-2002
    Corporate Author:
    National Center for Infectious Diseases (U.S.). Division of Quarantine.
    Published:
    2001
    Description:
    This book is published by the Division of Quarantine (DQ), National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), as a reference for those who advise international travelers of health risks. It is written primarily...
    File Type:
    Filetype[PDF - 2.24 MB]
  4. Use of Japanese Encephalitis Vaccine in US Travel Medicine Practices in Global TravEpiNet
    Personal Author:
    Deshpande, Bhushan R.; Rao, Sowmya R.; Jentes, Emily S.; Hills, Susan L.; Fischer, Marc; Gershman, Mark D.; Brunette, Gary W.; Ryan, Edward T.; LaRocque, Regina C.;
    Corporate Author:
    Global TravEpiNet Consortium
    Published:
    Jul 28 2014
    Source:
    Am J Trop Med Hyg. 2014; 91(4):694-698.
    Description:
    Few data regarding the use of Japanese encephalitis (JE) vaccine in clinical practice are available. We identified 711 travelers at higher risk and 7,578 travelers at lower risk for JE who were seen at US Global TravEpiNet sites from September of 200...
    File Type:
    Filetype[PDF - 654.72 KB]
  5. Inactivated Japanese encephalitis virus vaccine; recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Tsai, Theodore F.
    Corporate Author:
    United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Infectious Diseases (U.S.), Division of Vector-Borne Infectious Diseases.;
    Published:
    January 8, 1993
    Series:
    Morbidity and mortality weekly report. v. 42, no. RR-1 Recommendations and reports
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 42, no. RR-1
    Description:
    "Japanese encephalitis (JE) vaccine was available in the United States from 1983 through 1987 on an investigational basis, through travel clinics in collaboration with CDC (1). JE vaccine manufactured by Biken and distributed by Connaught Labora...
    Status:
    superseded
    File Type:
    Filetype[PDF - 263.65 KB]